Modulating effect of the PI3-kinase inhibitor LY294002 on cisplatin in human pancreatic cancer cells

被引：0
|
作者：
Masao Fujiwara
Kunihiko Izuishi
Takanori Sano
Mohammad Akram Hossain
Shoji Kimura
Tsutomu Masaki
Yasuyuki Suzuki
机构：
[1] Kagawa University,Department of Gastroenterological Surgery, Faculty of Medicine
[2] Kagawa University,Department of Pharmacology, Faculty of Medicine
[3] Kagawa University,Department of Gastroenterology and Neurology, Faculty of Medicine
来源：
Journal of Experimental & Clinical Cancer Research | / 27卷
关键词：
Pancreatic Cancer; Pancreatic Cancer Cell; Human Pancreatic Cancer Cell; Cell Death Detection ELISAPlus; Pancreatic Cancer Therapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Modulating effect of the PI3-kinase inhibitor LY294002 on cisplatin in human pancreatic cancer cells
    Fujiwara, Masao
    Izuishi, Kunihiko
    Sano, Takanori
    Hossain, Mohammad Akram
    Kimura, Shoji
    Masaki, Tsutomu
    Suzuki, Yasuyuki
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2008, 27 (1)
  • [2] The Commonly Used PI3-Kinase Probe LY294002 Is an Inhibitor of BET Bromodomains
    Dittmann, Antje
    Werner, Thilo
    Chung, Chun-Wa
    Savitski, Mikhail M.
    Savitski, Maria Faelth
    Grandi, Paola
    Hopf, Carsten
    Lindon, Matthew
    Neubauer, Gitte
    Prinjha, Rabinder K.
    Bantscheff, Marcus
    Drewes, Gerard
    ACS CHEMICAL BIOLOGY, 2014, 9 (02) : 495 - 502
  • [3] PI3-Kinase Inhibitor LY294002 Repressed the Expression of Thrombin-Activatable Fibrinolysis Inhibitor in Human Hepatoma HepG2 Cells
    Masuda, Yutaka
    Yazawa, Jun
    Makino, Yuuka
    Takada, Kimihiko
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2015, 38 (10) : 1529 - 1535
  • [4] Phosphatidylinositol 3 (PI 3)-kinase inhibitor LY294002 induces cell death in pancreatic carcinoma cells.
    Bondar, VM
    McConkey, D
    CLINICAL CANCER RESEARCH, 2001, 7 (11) : 3767S - 3767S
  • [5] PDE2 inhibition by the PI3 kinase inhibitor LY294002 and analogues
    Abbott, BM
    Thompson, PE
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (11) : 2847 - 2851
  • [6] Enhancement of mouse sperm motility by the PI3-kinase inhibitor LY294002 does not result in toxic effects on preimplantation embryo development
    Luconi, M
    Torcia, S
    Grillo, D
    Fiorenza, MT
    Forti, G
    Mangia, F
    Baldi, E
    HUMAN REPRODUCTION, 2005, 20 (12) : 3500 - 3504
  • [7] PI3K inhibitor LY294002, as opposed to wortmannin, enhances AKT phosphorylation in gemcitabine-resistant pancreatic cancer cells
    Wang, Yufeng
    Kuramitsu, Yasuhiro
    Baron, Byron
    Kitagawa, Takao
    Tokuda, Kazuhiro
    Akada, Junko
    Maehara, Shin-Ichiro
    Maehara, Yoshihiko
    Nakamura, Kazuyuki
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2017, 50 (02) : 606 - 612
  • [8] Exploring the specificity of the PI3K family inhibitor LY294002
    Gharbi, Severine I.
    Zvelebil, Marketa J.
    Shuttleworth, Stephen J.
    Hancox, Tim
    Saghir, Nahid
    Timms, John F.
    Waterfield, Michael D.
    BIOCHEMICAL JOURNAL, 2007, 404 : 15 - 21
  • [9] LY294002, an inhibitor of phosphatidylinositol-3-kinase, causes preferential induction of apoptosis in human multidrug resistant cells
    Nicholson, KM
    Quinn, DM
    Kellett, GL
    Warr, JR
    CANCER LETTERS, 2003, 190 (01) : 31 - 36
  • [10] Phosphatidylinositol 3-Kinase Inhibitor LY294002 Suppresses Proliferation and Sensitizes Doxorubicin Chemotherapy in Bladder Cancer Cells
    Wu, Deyao
    Tao, Jun
    Xu, Bin
    Qing, Weijie
    Li, Pengchao
    Lu, Qiang
    Zhang, Wei
    UROLOGIA INTERNATIONALIS, 2011, 86 (03) : 346 - 354
12345